ARTICLE | Politics, Policy & Law
Confluence of interests
Patient advocacy group EveryLife Foundation’s funding and focus
October 31, 2016 7:00 AM UTC
Pharmaceutical industry funding does not create an inherent conflict of interest for patient groups, according to Emil Kakkis, president of the EveryLife Foundation for Rare Diseases.
Kakkis, also president and CEO of rare and ultra-rare disease company Ultragenyx Pharmaceutical Inc., founded EveryLife in 2009 and continues to lead the foundation. ...
BCIQ Company Profiles